VEGFA and neoplasm: However, endothelial cell defects alone cannot explain the life-threatening hemorrhages in patients receiving anti-VEGF therapy; damage of the major vessel wall by tumor erosion, necrosis, cavitation and other pathologic conditions may have a role [10].